Literature DB >> 25832331

Prenatally diagnosed monochorionic diamniotic triplet pregnancy.

Naoto Yonetani1, Keisuke Ishii1, Aki Mabuchi1, Jun Sasahara1, Shusaku Hayashi1, Nobuaki Mitsuda1.   

Abstract

We present an extremely rare case of monochorionic diamniotic (MD) triplet pregnancy diagnosed via ultrasonography at the end of the first trimester that resulted in delivery of three healthy newborns. Ultrasonography for a 34-year-old woman at 12 weeks of gestation showed three fetuses and one placenta with a T-sign at the initial segment of the dividing membrane. Color Doppler examination revealed umbilical cord entanglement between two fetuses in one sac in addition to another sac containing one fetus. Therefore, this was diagnosed as MD triplet pregnancy. The triplets were delivered by cesarean section at 35 weeks of gestation and were healthy without neurological morbidities at the age of 28 days. Histopathological examination also revealed an MD triplet placenta. The possibility of MD triplet pregnancy should be recognized, although it is rare.
© 2015 The Authors. Journal of Obstetrics and Gynaecology Research © 2015 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  T-sign; first trimester; monochorionic diamniotic triplet pregnancy; ultrasonography; umbilical cord entanglement

Mesh:

Year:  2015        PMID: 25832331     DOI: 10.1111/jog.12688

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  2 in total

Review 1.  Intrafetal laser therapy in a monochorionic diamniotic triplet pregnancy with two acardiac fetuses: a case report and literature review.

Authors:  Guiqiong Huang; Hua Liao; Qing Hu; Xiaodong Wang; Haiyan Yu
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-23       Impact factor: 3.007

2.  Perinatal outcomes of monochorionic diamniotic triplet pregnancies: a case series.

Authors:  Tingting Xu; Xiaodong Wang; Haiyan Yu; Xinghui Liu
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-11       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.